Market Tracker

03/03 3:38am ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

38.23
Delayed Data
As of Mar 02
 +0.26 / +0.68%
Today’s Change
15.64
Today|||52-Week Range
38.50
+20.41%
Year-to-Date

Today’s Trading

Previous close37.97
Today’s open38.25
Day’s range37.82 - 38.50
Volume1,645,986
Average volume (3 months)1,323,628
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-14.14%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RCPTReceptos Inc+0.45+0.36%
GRFSGrifols SA-0.95-2.90%
NBIXNeurocrine Bioscienc...+1.38+3.53%
SGENSeattle Genetics Inc-0.25-0.69%
Data as of 4:00pm ET, 03/02/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
CAO
Uli Hacksell
Executive VP, Chief Financial &
Business Officer
Stephen R. Davis
Corporate headquarters
San Diego, California

Forecasts